Search Results 1131-1140 of 17115 for monoclonal antibody
... monoclonal antibody (mAb) targeting MET (such as onartuzumab [MetMAb]); The subject has received radionuclide treatment =< 6 weeks of the first dose of study ...
For prior biological therapies (e.g., monoclonal antibodies with a half-life longer than 3 days), the interval must be at least 28 days prior to the first dose ...
History of allergy or hypersensitivity to human, humanized or chimeric monoclonal antibodies; Exposure to another investigational drug within 42 days of ...
Known severe allergic reactions to TCZ or other monoclonal antibodies. Active TB infection. Suspected active bacterial, fungal, viral, or other infection ...
Description. Immune globulin-hipp injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...
Prior anti-cancer monoclonal antibody (mAb) for direct anti-neoplastic treatment within 4 weeks prior to study Day 1 or who has not recovered from adverse ...
History of severe allergic or anaphylactic reaction to monoclonal antibody therapy. Confirmed diagnosis of progressive multifocal leukoencephalopathy ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
... monoclonal B-cell lymphocytosis. Br J Haematol ... Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis. ... Incidence, risk ...
It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is also used to treat immunoglobulin G4-related disease (IgG4-RD), a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.